Did India's price control policy for coronary stents create unintended consequences?

Deo, S and Tyagi, Hanu and Chatterjee, C and Molakapuri, Himasagar (2020) Did India's price control policy for coronary stents create unintended consequences? Social Science & Medicine, 246. ISSN 0277-9536

Full text not available from this repository. (Request a copy)


In February 2017, India capped the retail price of coronary stents and restricted the channel margin to bring Percutaneous Transluminal Coronary Angioplasty (PTCA) procedure, which uses coronary stents, within reach of millions of patients who previously could not afford it. Prior research shows that care providers respond to such regulations in a way that compensates for their loss in profits because of price control. Therefore, price control policies often introduce unintended consequences, such as distortions in clinical decision making. We investigate such distortions through empirical analysis of claims data from a representative public insurance program in the Indian state of Karnataka. Our data comprises 25,769 insurance claims from 69 private and seven public hospitals from February 2016 to February 2018.

Affiliation: Indian School of Business
ISB Creators:
ISB CreatorsORCiD
Deo, Shttp://orcid.org/0000-0002-3233-6014
Item Type: Article
Uncontrolled Keywords: Healthcare, Price Control,Coronary Artery Bypass Graft, karnataka, Percutaneous Transluminal Coronary Angioplasty
Depositing User: Mohan Dass
Date Deposited: 18 Apr 2020 03:47
Last Modified: 18 Apr 2020 04:01
URI: http://eprints.exchange.isb.edu/id/eprint/1360
Publisher URL: https://doi.org/10.1016/j.socscimed.2019.112737
Publisher OA policy: http://sherpa.ac.uk/romeo/issn/0277-9536/
Related URLs:

Actions (login required)

View Item View Item
Statistics for DESI ePrint 1360 Statistics for this ePrint Item